Answer
At the NURTURE interim analysis, all 25 presymptomatic infants receiving Spinraza (nusinersen sodium) had achieved sitting without support, 23 (92%) were walking with assistance, and 22 (88%) had achieved walking alone.
Sources for this answer
- Spinraza 50 mg solution for injectionBiogen Idec Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked